Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | GMNN | O75496 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | SHBG | P04278 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30400827 | 0.98 | TP53 (0.46) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL4535941 | 0.94 | TP53 (0.48) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL31562869 | 0.92 | TP53 (0.47) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL8413380 | 0.92 | TP53 (0.47) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL11607011 | 0.92 | TP53 (0.47) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL2858662 | 0.92 | TP53 (0.47) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL1663576 | 0.91 | TP53 (0.45) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL3427003 | 0.89 | TP53 (0.43) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL887649 | 0.86 | TP53 (0.54) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL12134655 | 0.86 | TP53 (0.54) | TP53KDM4EGMNNLMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109735168-B | Application of cyclanol as additive in preparation of quantum dot ink, quantum dot ink and preparation method of quantum dot ink | 广东聚华印刷显示技术有限公司 | 2022-03-18 | — | — | CN | claimed |
| CN-110085749-B | Quantum dot ink, preparation method thereof and quantum dot light-emitting device | 广东聚华印刷显示技术有限公司 | 2021-07-20 | — | — | CN | claimed |
| CN-110085748-B | Quantum dot ink, preparation method thereof and quantum dot light-emitting device | 广东聚华印刷显示技术有限公司 | 2021-06-29 | — | — | CN | claimed |
| CN-112679942-A | Deodorant leisure shoes and preparation process thereof | 莆田永生鞋业有限公司 | 2021-04-20 | — | — | CN | claimed |
| CN-110156620-A | A kind of preparation method of tranexamic acid | 中节能万润股份有限公司 | 2019-08-23 | — | — | CN | claimed |
| CN-110085748-A | Quantum dot ink and preparation method thereof and quantum dot light emitting device | 广东聚华印刷显示技术有限公司 | 2019-08-02 | — | — | CN | claimed |
| CN-110079159-A | Quantum dot ink and preparation method thereof | 广东聚华印刷显示技术有限公司 | 2019-08-02 | — | — | CN | claimed |
| CN-110085749-A | Quantum dot ink and preparation method thereof and quantum dot light emitting device | 广东聚华印刷显示技术有限公司 | 2019-08-02 | — | — | CN | claimed |
| CN-110079161-A | Nano metal ink and preparation method thereof | 广东聚华印刷显示技术有限公司 | 2019-08-02 | — | — | CN | claimed |
| CN-109735168-A | Cycloalkane alcohol is preparing the application in quantum dot ink, quantum dot ink and preparation method thereof as additive | 广东聚华印刷显示技术有限公司 | 2019-05-10 | — | — | CN | claimed |
| CN-101495919-B | Positive photosensitive resin composition, method for preparing cured relief pattern, semiconductor device | ASAHI KASEI E MATERIALS CORP | 2015-05-06 | — | — | CN | claimed |
| US-12564551-B2 | Composition or oat extract comprising avenanthramide and β-glucan | SYMRISE AG (DE) | 2026-03-03 | — | — | US | disclosed |
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | SYMRISE AG (DE) | 2026-02-12 | — | — | US | disclosed |
| US-20250041179-A1 | ANTIMICROBIAL COMBINATIONS | SYMRISE AG (DE) | 2025-02-06 | — | — | US | disclosed |
| CN-119100909-A | Preparation method for synthesizing high-purity cyclopentanol from cyclopentanone | 重庆康乐制药有限公司 | 2024-12-10 | — | — | CN | disclosed |
| US-5763586-A | Extraction of proteins from naturally occuring membranes | ANATRACE, INC. (US) | 1998-06-09 | — | — | US | disclosed |
| US-5674987-A | Extraction of proteins from naturally occurring membranes | ANATRACE, INC. (US) | 1997-10-07 | — | — | US | disclosed |
| US-4719105-A | Method, compositions and compounds useful in room fresheners employing cyclohexyl alcohol and ester derivatives | BUSH BOAKE ALLEN, INC. (GB) | 1988-01-12 | — | — | US | disclosed |
| US-4622221-A | Method, compositions and compounds, useful in room fresheners employing cyclohexyl alcohol and ester derivatives | BUSH BOAKE ALLEN INC. (US) | 1986-11-11 | — | — | US | disclosed |
| US-4187251-A | DEODORIZING, ALKYLCYCLOHEXYL ALKYL KETONES | SCHLEPPNIK ALFRED A | 1980-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12564551-B2 | Composition or oat extract comprising avenanthramide and β-glucan | CUTA, HLA-A, OAT | TP53 2356/4885KDM4E 4062/4885GMNN 2050/4885 |
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | TLR7, MYC, ERG28 | TP53 1644/4885KDM4E 4297/4885GMNN 3929/4885 |
| US-20250041179-A1 | ANTIMICROBIAL COMBINATIONS | C9, POLR1C, C1S | TP53 3513/4885KDM4E 3208/4885GMNN 3917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.